155 related articles for article (PubMed ID: 34449465)
1. Fasting blood glucose was linearly associated with colorectal cancer risk in the population without self-reported diabetes mellitus history.
Wu J; He H; Zhang Q; Zhang Y
Medicine (Baltimore); 2021 Aug; 100(34):e26974. PubMed ID: 34449465
[TBL] [Abstract][Full Text] [Related]
2. Elevated fasting serum glucose levels increase the risk of hepatocellular carcinoma: A prospective cohort study.
Liu T; Wang W; Cui H; Sun M; Wang Y; Liu X; Cao L; Liu H; Liu S
Medicine (Baltimore); 2019 Jul; 98(30):e16369. PubMed ID: 31348238
[TBL] [Abstract][Full Text] [Related]
3. Fasting glucose and risk of colorectal cancer in the Korean Multi-center Cancer Cohort.
Park H; Cho S; Woo H; Park SK; Shin HR; Chang SH; Yoo KY; Shin A
PLoS One; 2017; 12(11):e0188465. PubMed ID: 29161326
[TBL] [Abstract][Full Text] [Related]
4. Association between fasting serum glucose levels and incidence of colorectal cancer in Korean men: the Korean Cancer Prevention Study-II.
Shin HY; Jung KJ; Linton JA; Jee SH
Metabolism; 2014 Oct; 63(10):1250-6. PubMed ID: 25113383
[TBL] [Abstract][Full Text] [Related]
5. Fasting Blood Glucose Variability and Unfavorable Trajectory Patterns Are Associated with the Risk of Colorectal Cancer.
Jun H; Lee J; Lee HA; Kim SE; Shim KN; Jung HK; Jung SA; Moon CM
Gut Liver; 2022 May; 16(3):423-432. PubMed ID: 34593671
[TBL] [Abstract][Full Text] [Related]
6. Impaired fasting glucose, single-nucleotide polymorphisms, and risk for colorectal cancer in Koreans.
Jung KJ; Kim MT; Jee SH
Epidemiol Health; 2016; 38():e2016002. PubMed ID: 26797220
[TBL] [Abstract][Full Text] [Related]
7. The association between fasting blood glucose and the risk of primary liver cancer in Chinese males: a population-based prospective study.
Feng X; Wang G; Li N; Lyu Z; Chen S; Wei L; Chen Y; Xie S; Yang W; Yin J; Cui H; Chen H; Ren J; Shi J; Wu S; Dai M; He J
Br J Cancer; 2017 Oct; 117(9):1405-1411. PubMed ID: 28873085
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Serum Glucose and Kidney Disease Progression Among Patients With Diabetes.
Jung HH
JAMA Netw Open; 2021 Sep; 4(9):e2127387. PubMed ID: 34586368
[TBL] [Abstract][Full Text] [Related]
9. Separate and combined effect of visit-to-visit glycaemic variability and mean fasting blood glucose level on all-cause mortality in patients with type 2 diabetes: A population-based cohort study.
Liu Y; Xu H; Li J; Yang Y; Zhang J; Liu X; Li J; Yu Y; Qin G
Diabetes Obes Metab; 2022 Dec; 24(12):2400-2410. PubMed ID: 35876225
[TBL] [Abstract][Full Text] [Related]
10. The association between fasting blood glucose trajectory and cancer risk in Chinese population without diabetes.
Feng X; Wang G; Lyu Z; Chen S; Wei L; Li X; Wen Y; Chen Y; Xie S; Cui H; Chen H; Li J; Lin C; Ren J; Shi J; Wu S; Dai M; Li N; He J
Int J Cancer; 2020 Aug; 147(4):958-966. PubMed ID: 31900925
[TBL] [Abstract][Full Text] [Related]
11. Fasting serum glucose level and cancer risk in Korean men and women.
Jee SH; Ohrr H; Sull JW; Yun JE; Ji M; Samet JM
JAMA; 2005 Jan; 293(2):194-202. PubMed ID: 15644546
[TBL] [Abstract][Full Text] [Related]
12. Long-term fasting glucose variability and risk of cancer in patients with type 2 diabetes mellitus: A retrospective population-based cohort study in Shanghai.
Cui XR; Li J; Yang YT; Wu JY; Xu HL; Yu YF; Qin GY
J Diabetes; 2022 Nov; 14(11):727-738. PubMed ID: 36353746
[TBL] [Abstract][Full Text] [Related]
13. Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers.
Limburg PJ; Stolzenberg-Solomon RZ; Vierkant RA; Roberts K; Sellers TA; Taylor PR; Virtamo J; Cerhan JR; Albanes D
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1514-21. PubMed ID: 17162243
[TBL] [Abstract][Full Text] [Related]
14. Diabetes, plasma glucose and incidence of colorectal cancer in Chinese adults: a prospective study of 0.5 million people.
Pang Y; Kartsonaki C; Guo Y; Chen Y; Yang L; Bian Z; Bragg F; Millwood IY; Shen L; Zhou S; Liu J; Chen J; Li L; Holmes MV; Chen Z
J Epidemiol Community Health; 2018 Oct; 72(10):919-925. PubMed ID: 29970599
[TBL] [Abstract][Full Text] [Related]
15. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.
Richter B; Hemmingsen B; Metzendorf MI; Takwoingi Y
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012661. PubMed ID: 30371961
[TBL] [Abstract][Full Text] [Related]
16. Association of fasting glucose levels with incident atherosclerotic cardiovascular disease: An 8-year follow-up study in a Chinese population.
Liu F; Yang X; Li J; Cao J; Chen J; Li Y; Liu X; Zhao L; Shen C; Yu L; Huang J; Gu D
J Diabetes; 2017 Jan; 9(1):14-23. PubMed ID: 26840038
[TBL] [Abstract][Full Text] [Related]
17. Cancer risk according to fasting blood glucose trajectories: a population-based cohort study.
Khong TMT; Bui TT; Kang HY; Lee J; Park E; Oh JK
BMJ Open Diabetes Res Care; 2024 Feb; 12(1):. PubMed ID: 38413174
[TBL] [Abstract][Full Text] [Related]
18. Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS).
Boden-Albala B; Cammack S; Chong J; Wang C; Wright C; Rundek T; Elkind MS; Paik MC; Sacco RL
Diabetes Care; 2008 Jun; 31(6):1132-7. PubMed ID: 18339972
[TBL] [Abstract][Full Text] [Related]
19. The association between blood glucose value and long-term mortality.
Wändell PE; Theobald H
Diabetes Metab; 2005 Dec; 31(6):588-94. PubMed ID: 16357808
[TBL] [Abstract][Full Text] [Related]
20. Optimal fasting glucose levels with regard to cardiovascular and mortality outcomes in people treated with or without antidiabetic medication.
Jung HH; Lee S
Diabetes Obes Metab; 2020 Feb; 22(2):243-253. PubMed ID: 31602755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
